Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 3353
  • 3354
  • 3355
  • …
  • ›
  • »

2026-03-27

Clinuvel Showcases AI-Powered Vitiligo Assessment Tool at AAD Conference

2026-03-27

Research: BofAS Lowers TP for CSPC Pharmaceutical to HKD8, Rating 'Underperform'

2026-03-27

Research: Nomura: CSPC Pharmaceutical Last Year's Net Profit Far Below Expectations Due to One-off Factors

2026-03-27

Research: BofAS Raises TP for CHONGQING RURAL COMMERCIAL BANK to HKD8.39, Maintains 'Buy' Rating

2026-03-27

INNOVENT BIO Soars 6%+ as It Records First Annual Profit of RMB814M

2026-03-27

Research: CMBI Raises TP of NONGFU SPRING to HKD60.88, Maintains 'Buy' Rating

2026-03-27

Innovent Shares Jump on First Profit, Obesity Drug Momentum

2026-03-27

This ASX steel stock is unlocking hidden value. So why is it falling today?

2026-03-27

LIVZON PHARMACEUTICAL Subsidiary's Drug Approved for Adult Schizophrenia Clinical Trial

2026-03-27

DBS Joins Buzzing India ECM Space With Mandate in $1 Billion IPO

2026-03-27

Results: Linklogis Turns Loss to Profit, Earning RMB1.664 Billion for Full Year

2026-03-27

BIOCYTOGEN Partner NEOK Bio's Bispecific ADC NEOK002 Approved for US Clinical Trial

  • «
  • ‹
  • …
  • 3353
  • 3354
  • 3355
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies